WuXi AppTec (OTCMKTS:WUXAY) Shares Gap Up – Still a Buy?

Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAYGet Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $18.50, but opened at $19.3550. WuXi AppTec shares last traded at $19.3550, with a volume of 121 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy”.

Get Our Latest Stock Analysis on WuXi AppTec

WuXi AppTec Price Performance

The company’s fifty day moving average is $16.61 and its 200 day moving average is $15.19.

WuXi AppTec (OTCMKTS:WUXAYGet Free Report) last posted its quarterly earnings data on Monday, April 27th. The company reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $1.82 billion during the quarter, compared to analysts’ expectations of $1.59 billion.

About WuXi AppTec

(Get Free Report)

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.

See Also

Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.